Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Leukotrienes (LTs) are a group of acute inflammatory mediators derived from arachidonic acid in leukocytes. The majority of these metabolites are formed through the 5-lipoxygenase (5-LO) pathway.1 14,15-Leukotriene E4 (14,15-LTE4) is a metabolite of 14,15-LTC4 and 14,15-LTD4, an alternate class of LTs synthesized by a pathway involving the dual actions of 15- and 12-LOs on arachidonic acid via 15-HpETE and 14,15-LTA4 intermediates.2,3,4,5 These metabolites are classified as eoxins because they are formed mostly by eosinophils.4 Mast cells and nasal polyps can synthesize 14,15-LTC4 as well, however metabolism to 14,15-LTE4 in these cells and tissue has not been documented. 14,15-LTE4 increases vascular permeability of human endothelial cell monolayers with about 10-
WARNING This product is not for human or veterinary use.
1. Leukotriene synthesis by epithelial cells. Histol. Histopathol. 18(2), 587-595 (2003).
2. Arachidonate 12-
3. Leukotriene formation by a purified reticulocyte lipoxygenase enzyme. Conversion of arachidonic acid and 15-
4. Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-
5. Sheep uterus dual lipoxygenase in the synthesis of 14,15-
High levels of eicosanoids and docosanoids in the lungs of intubated COVID-
Lipid storm within the lungs of severe COVID-